New perspectives on treatment of gastrointestinal diseases: therapeutic potential of mesenchymal stromal cells
-
Published:2022-10-10
Issue:3
Volume:67
Page:
-
ISSN:2587-5779
-
Container-title:Biological Communications
-
language:
-
Short-container-title:BioComm
Author:
Payushina OlgaORCID, Tsomartova DibakhanORCID, Chereshneva YelizavetaORCID, Ivanova MarinaORCID, Pashina NataliyaORCID, Tsomartova ElinaORCID, Kuznetsov SergeyORCID
Abstract
Mesenchymal stromal cells (MSCs) are a promising resource for cell therapy of different organs and systems, including the gastrointestinal tract (GIT). Therapeutic effect of MSC transplantation in GIT diseases may be partly due to their differentiation into various cellular components of the digestive tube. However, more significant is regulatory influence of MSCs on survival, proliferation, and differentiation of the gastric and intestinal epithelial cells, as well as their immunomodulatory, pro-angiogenic and antifibrotic effects. Data from experiments on animals and clinical trials indicate prospect of using MSCs in various diseases affecting any parts of GIT. However, effective and safe clinical use of MSCs requires an in-depth study of the mechanisms of their therapeutic effect, the development of optimal methods of administration, and risk assessment of adverse effects. This review analyzes MSC participation in regeneration of GIT and systematizes data on the potential of using MSCs in the treatment of gastroenterological diseases.
Publisher
Saint Petersburg State University
Subject
General Agricultural and Biological Sciences,General Biochemistry, Genetics and Molecular Biology
Reference127 articles.
1. Accarie, A., l'Homme, B., Benadjaoud, M. A., Lim, S. K., Guha, C., Benderitter, M., Tamarat, R., and Sémont, A. 2020. Extracellular vesicles derived from mesenchymal stromal cells mitigate intestinal toxicity in a mouse model of acute radiation syndrome. Stem Cell Research & Therapy 11(1):371. https://doi.org/10.1186/s13287-020-01887-1 2. Adas, G., Kemik, O., Eryasar, B., Okcu, A., Adas, M., Arikan, S., Erman, G., Kemik, A. S., Kamali, G., Dogan, Y., and Karaoz, E. 2013. Treatment of ischemic colonic anastomoses with systemic transplanted bone marrow derived mesenchymal stem cells. European Review for Medical and Pharmacological Sciences 17(17):2275–2285. 3. Akduman, H., Dilli, D., Ergün, E., Çakmakçı, E., Çelebi, S. K., Çitli, R., and Zenciroğlu, A. 2021. Successful mesenchymal stem cell application in supraventricular tachycardia-related necrotizing enterocolitis: a case report. Fetal and Pediatric Pathology 40(3):250–255. https://doi.org/10.1080/15513815.2019.1693672 4. Alazzouni, A. S., Fathalla, A. S., Gabri, M. S., Dkhil, M. A., and Hassan, B. N. 2020. Role of bone marrow derived-mesenchymal stem cells against gastric ulceration: Histological, immunohistochemical and ultrastructural study. Saudi Journal of Biological Sciences 27(12):3456–3464. https://doi.org/10.1016/j.sjbs.2020.09.044 5. Al-Hakami, A., Alqhatani, S. Q., Shaik, S., Jalfan, S. M., Dhammam, M. S. A., Asiri, W., Alkahtani, A. M., Devaraj, A., and Chandramoorthy, H. C. 2020. Cytokine physiognomies of MSCs from varied sources confirm the regenerative commitment post-coculture with activated neutrophils. Journal of Cellular Physiology 235(11):8691–8701. https://doi.org/10.1002/jcp.29713
|
|